![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Publisher: Adis International
ISSN: 1173-5503
Source: PharmacoEconomics and Outcomes News, Vol.1, Iss.366, 2002-01, pp. : 2-2
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Imaging Modalities for Perianal Crohn's Disease
Current Drug Targets, Vol. 13, Iss. 10, 2012-09 ,pp. :
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Infliximab promising in paediatric Crohn's disease
Inpharma, Vol. 1, Iss. 1391, 2003-01 ,pp. :
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Infliximab: additional benefits in Crohn's disease
Inpharma, Vol. 1, Iss. 1349, 2002-01 ,pp. :
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Infliximab worth it for Crohn's disease in the UK
Inpharma, Vol. 1, Iss. 1515, 2005-01 ,pp. :